C07K 14/335
From lactobacillus
Official title: from Lactobacillus (G)
C07K14/335 (From lactobacillus) appears on 138 US grants and 227 published applications in this corpus.
Search patents in C07K- Granted patents
- 138
- Published applications
- 227
- Assignees
- 129
- Inventors
- 466
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 1 |
| 2002 | 2 | 5 |
| 2003 | 2 | 10 |
| 2004 | 3 | 7 |
| 2005 | 3 | 9 |
| 2006 | 5 | 8 |
| 2007 | 7 | 10 |
| 2008 | 9 | 5 |
| 2009 | 7 | 16 |
| 2010 | 13 | 14 |
| 2011 | 5 | 9 |
| 2012 | 3 | 5 |
| 2013 | 6 | 4 |
| 2014 | 5 | 13 |
| 2015 | 5 | 10 |
| 2016 | 6 | 4 |
| 2017 | 1 | 5 |
| 2018 | 4 | 2 |
| 2019 | 2 | 8 |
| 2020 | 4 | 13 |
| 2021 | 5 | 11 |
| 2022 | 8 | 13 |
| 2023 | 8 | 19 |
| 2024 | 9 | 11 |
| 2025 | 8 | 10 |
| 2026 | 3 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Materials and methods for inhibiting a viral infection, including a coronavirus infection16 Jun 2026US 12,653,849 B2Quorum Innovations, LLC
- Lactic acid bacteria strain—antibacterial peptides produced by said strain and related pharmaceutical compositions2 Jun 2026US 12,642,827 B2Add2Life GmbH
- Genetically modified Lactobacillus and uses thereof14 Apr 2026US 12,599,637 B2BiomEdit, Inc.
- Protective barrier compositions, and uses thereof16 Dec 2025US 12,495,800 B2Quorum Innovations, LLC
- Probiotic compositions comprising lactobacillus reuteri strains and methods of use30 Sep 2025US 12,427,174 B2BiomEdit, Inc.
- Non-covalent binding peptide and carrier complex comprising it27 Aug 2026US 2026/0250334 A1Consejo Superior de Investigaciones Cientificas
- Materials and methods for inhibiting a viral infection, including a coronavirus infection6 Aug 2026US 2026/0224649 A1Quorum Innovations, LLC
- Genetically modified lactobacillus and uses thereof23 Jul 2026US 2026/0207686 A1BiomEdit, Inc.
- Compositions and methods involving probiotic molecules21 May 2026US 2026/0137828 A1MicroSintesis Inc.
- Novel Genetic Tools12 Mar 2026US 2026/0071226 A1
Most cited
By later US patents
- Salt-inducible promoter derivable from a lactic acid bacterium, and its use in a lactic acid bacterium for production of a desired protein66US 6,140,078 AUnilever Patent Holdings B.V. · 2000
- Protein having cell growth stimulating action, composition thereof and method for producing the same36US 4,604,234 ASanwa Kagaku Kenyusho Co., Ltd. · 1986
- Polynucleotides, materials incorporating them, and methods for using them35US 6,476,209 B1Genesis Research & Development Corporation Limited · 2002
- Lactobacilli harboring aggregation gene as a vaccine delivery vehicle33US 6,100,388 ABioGaia Biologies AB · 2000
- Lactobacillus acidophilus nucleic acid sequences encoding stress-related proteins and uses therefor30US 7,608,700 B2North Carolina State University · 2009